17-63896135-G-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001317.6(CSH1):​c.111C>A​(p.Asp37Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00080 ( 0 hom., cov: 5)
Exomes 𝑓: 0.00015 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CSH1
NM_001317.6 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.05
Variant links:
Genes affected
CSH1 (HGNC:2440): (chorionic somatomammotropin hormone 1) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones and plays an important role in growth control. The gene is located at the growth hormone locus on chromosome 17 along with four other related genes in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. Although the five genes share a remarkably high degree of sequence identity, they are expressed selectively in different tissues. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed mainly in the placenta and utilizes multiple transcription initiation sites. Expression of the identical mature proteins for chorionic somatomammotropin hormones 1 and 2 is upregulated during development, although the ratio of 1 to 2 increases by term. Mutations in this gene result in placental lactogen deficiency and Silver-Russell syndrome. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025169969).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CSH1NM_001317.6 linkuse as main transcriptc.111C>A p.Asp37Glu missense_variant 2/5 ENST00000316193.13 NP_001308.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CSH1ENST00000316193.13 linkuse as main transcriptc.111C>A p.Asp37Glu missense_variant 2/51 NM_001317.6 ENSP00000316416 P1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
24
AN:
29956
Hom.:
0
Cov.:
5
FAILED QC
Gnomad AFR
AF:
0.00718
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000257
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000153
AC:
106
AN:
690610
Hom.:
0
Cov.:
9
AF XY:
0.000116
AC XY:
41
AN XY:
353100
show subpopulations
Gnomad4 AFR exome
AF:
0.00562
Gnomad4 AMR exome
AF:
0.000340
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000573
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000204
Gnomad4 OTH exome
AF:
0.000306
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000802
AC:
24
AN:
29936
Hom.:
0
Cov.:
5
AF XY:
0.000698
AC XY:
10
AN XY:
14328
show subpopulations
Gnomad4 AFR
AF:
0.00717
Gnomad4 AMR
AF:
0.000257
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000144
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 09, 2021The c.111C>A (p.D37E) alteration is located in exon 2 (coding exon 2) of the CSH1 gene. This alteration results from a C to A substitution at nucleotide position 111, causing the aspartic acid (D) at amino acid position 37 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
2.1
DANN
Benign
0.96
DEOGEN2
Benign
0.30
T;D;D
Eigen
Benign
-0.98
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.55
D
LIST_S2
Benign
0.54
T;T;T
M_CAP
Uncertain
0.092
D
MetaRNN
Benign
0.025
T;T;T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
1.3
.;L;.
MutationTaster
Benign
1.0
D;N;N;N
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.7
N;N;N
REVEL
Benign
0.081
Sift
Benign
0.11
T;T;T
Sift4G
Benign
0.66
T;T;T
Polyphen
0.041
B;.;B
Vest4
0.043
MutPred
0.48
Gain of disorder (P = 0.2344);Gain of disorder (P = 0.2344);Gain of disorder (P = 0.2344);
MVP
0.16
MPC
1.0
ClinPred
0.073
T
GERP RS
1.6
Varity_R
0.14
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1282514914; hg19: chr17-61973495; API